Psyence Biomedical (PBM) Shares Rise on Strategic Collaboration News
Psyence Biomedical Ltd. (NASDAQ: PBM) saw its shares advance by 7.59% to $5.81 today, driven by positive developments in a strategic collaboration. The upward momentum follows news that its partner, PsyLabs – a leading producer of purified psychedelic compounds – has successfully manufactured a GMP-aligned Ibogaine Total Alkaloid extract. An authorized third-party laboratory confirmed that […]